ATS 2023: Dupilumab Reduces Exacerbations in COPD With Type 2 Inflammation
Lung function, quality of life, and respiratory symptoms also improved
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Lung function, quality of life, and respiratory symptoms also improved
Only registered members have full access to PracticeUpdate content.